Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class B (BIO.B)
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
In addition, growth across international markets boosts the stock's appeal. Meanwhile, a dull macro scenario and unfavorable foreign exchange may restrict Bio-Rad's full growth potential. In the past six months, shares of this Zacks Rank #3 (Hold) company have risen 28.1% against the industry's 6.5% decline. The S&P 500 composite has seen a 12.8% rise in the same time frame. The renowned manufacturer and global supplier of clinical diagnostics and life science research products has a market capitalization of $8.44 billion. Bio-Rad's earnings surpassed estimates in two of the trailing four quarters and missed in the other two, the average surprise being 19.8%. Let's delve deeper. Clinical Diagnostics Continues to Gain Momentum : The business has now returned to its normalized growth rate post-pandemic, maintaining strong market positions globally for its platforms. Built on its long-standing reputation as a leading blood screening systems provider, Bio-Rad's IH-500 blood typing
Show less
Read more
Impact Snapshot
Event Time:
BIO.B
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO.B alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO.B alerts
High impacting Bio-Rad Laboratories, Inc. Class B news events
Weekly update
A roundup of the hottest topics
BIO.B
News
- Gruve raises $50 million to solve what its CEO calls AI's biggest problem: power [Business Insider]Business Insider
- Bio-Rad Laboratories Still Hampered By Underwhelming Core Growth [Seeking Alpha]Seeking Alpha
- A Look At The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO) [Yahoo! Finance]Yahoo! Finance